College of Veterinary Medicine

Research in VCAPP

Raymond Quock, Ph.D.


  Quock

Professor and Department Chair
Pharmaceutical Sciences, College of Pharmacy
E-Mail: quockr@wsu.edu
Pharmacy site: http://www.pharmacy.wsu.edu/pharmSci/quock.html
Phone: (509) 335-5545

One major research emphasis in our laboratory focuses on the pharmacology of the anesthetic gas nitrous oxide (N2O), also known as laughing gas? We have spent the past nearly 20 years characterizing the analgesic properties of N2O and were the first to provide chemical evidence that N2O stimulates the neuronal release of endogenous opioid peptides that then activate opioid receptors in the brain and spinal cord.

Our research has used quantitative trait loci (QTL) localization to identify markers in the mouse genome that are significantly associated with responsiveness to N2O and have implicated the biological regulator nitric oxide (NO) as a critical determinant of the analgesic mechanism of action of N2O. Current research is elucidating the role of NO in the mechanism that regulates neuronal release of opioid peptides.

Our more recent work has extended into study of the effects of another medical gas, hyperbaric action (HBO2), which is the clinical application of 100% oxygen at higher than atmospheric pressures for limited periods of time (60-90 min) to achieve therapeutic outcomes.  HBO2 treatment produces a number of beneficial effects, not the least of which is pain relief.  There are similarities between the antinociceptive effect of HBO2 and that of N2O.  Current research is focused on identification of potential molecular targets in the brain that might trigger the longer-lasting antinociceptive response to HBO2 treatment.

The present research into the mechanisms of antinociceptive action of HBO2 and N2O utilizes a combination of stereotaxic neurosurgical, behavioral, pharmacological, neurochemical, microdialysis, pharmacogenetic and molecular biology approaches.  

Biographical Information

Raymond M. Quock, Professor, obtained his B.S. degree in biology from the University of San Francisco in 1970 and his Ph.D. in pharmacology from the University of Washington in 1974. He spent one year as an instructor in pharmacology at the University of Washington (1974-75) and the next four years as an assistant professor of pharmacology at the University of Pacific School of Pharmacy in Stockton, California (1975-79).  Dr. Quock then worked at the Marquette University School of Dentistry in Milwaukee, Wisconsin (1979-89), moving through the ranks of assistant professor, associate professor and eventually to full professor. He also held adjunct positions at the Medical College of Wisconsin and the V.A. Medical Center.  He then left Milwaukee for the University of Illinois College of Medicine at Rockford (1989-98), where he was professor of pharmacology and also adjunct professor of pharmacology in anesthesiology at the University of Illinois College of Medicine in Chicago (1993-98).  Dr. Quock joined Washington State University as professor and chair of pharmaceutical sciences in the College of Pharmacy in January 1999.  He is a member of both the Neuroscience and Pharmacology/Toxicology graduate programs.  After returning to teaching and research in 2002. He was appointed to a second term as department chair in July 2007 and was named the Allen I. White Professor in August 2007.

Recent Publications

L.K. Vaughn and R.M. Quock..  Nitrous oxide and opioid receptors.  In:  Willis, W.D. and R.F. Schmidt, eds.  Encyclopedia of Pain, pp. 1347-1349.  Springer-Verlag, Berlin Heidelberg New York (2007) 

D.E. Emmanouil and R.M. Quock..  Advances in understanding the actions of nitrous oxide.  Anesthesia Progress 54(1):9-18 (2007) 

R.J. Pruhs, R.T. Pea and R.M. Quock.. Antagonism of phosphoramidon-induced antinociception in mice by μ- but not κ-opioid receptor blockers.  Life Sciences 80(19):1817-1820 (2007) 

Y. Matsushita, M. Ishikawa, K. Abe, I. Utsunomiya, K. Hoshi, R.M. Quock. and K. Taguchi.  Protein kinase Cγ is a key enzyme in the development of tolerance to nitrous oxide-induced antinociception in mice.  Neuroscience 148(2):541-547 (2007)  

D.E. Emmanouil, A.S. Dickens, R.W. Heckert, Y. Ohgami, E. Chung, S. Han and R.M. Quock..   Nitrous oxide-antinociception is mediated by opioid receptors and nitric oxide in the periaqueductal gray region of the brain.  European Neuropsychopharmacology 18(3):194199 (2008)  

Y. Ohgami, E. Chung, D.Y. Shirachi and R.M. Quock..  Influence of hyperbaric oxygen on regional brain levels and spinal cord levels of nitric oxide metabolites in rat.  Brain Research Bulletin 75(3):668-673 (2008)
Last Edited: Sep 04, 2009 10:13 AM   

Department of VCAPP PO Box 646520, Washington State University, Pullman WA 99164-6520, 509-335-6624, Contact Us  Safety Links